Evidence map›Paper›PMID 25769722›Full record

ArticleCancer research2015

Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating Cells.

Nicholas Borcherding, David Kusner, Ryan Kolb, Qing Xie, Wei Li, Fang Yuan, Gabriel Velez, Ryan Askeland, Ronald J Weigel, Weizhou Zhang

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. The Wnt Signalling Pathway: A Tailored Target in Cancer.International journal of molecular sciences · 2020
    Review
  17. Review
  18. Article
  19. Article
  20. FAT1 inhibits the proliferation and metastasis of cervical cancer cells by binding β-catenin.International journal of clinical and experimental pathology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Nicholas BorcherdingDepartment of Pathology, University of Iowa, College of Medicine, Iowa City, Iowa. Medical Science Training Program, University of Iowa, College of Medicine, Iowa City, Iowa.
David KusnerDepartment of Pathology, University of Iowa, College of Medicine, Iowa City, Iowa. Molecular and Cellular Biology Program, University of Iowa, College of Medicine, Iowa City, Iowa.
Ryan KolbDepartment of Pathology, University of Iowa, College of Medicine, Iowa City, Iowa. Immunology Program, University of Iowa, College of Medicine, Iowa City, Iowa.
Qing XieDepartment of Pathology, University of Iowa, College of Medicine, Iowa City, Iowa. College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, P.R. China.
Wei LiDepartment of Pathology, University of Iowa, College of Medicine, Iowa City, Iowa.
Fang YuanDepartment of Pathology, University of Iowa, College of Medicine, Iowa City, Iowa. Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China.
Gabriel VelezMedical Science Training Program, University of Iowa, College of Medicine, Iowa City, Iowa.
Ryan AskelandDepartment of Pathology, University of Iowa, College of Medicine, Iowa City, Iowa.
Ronald J WeigelDepartment of Surgery, University of Iowa, College of Medicine, Iowa City, Iowa. Holden Comprehensive Cancer Center, University of Iowa, College of Medicine, Iowa City, Iowa.
Weizhou ZhangDepartment of Pathology, University of Iowa, College of Medicine, Iowa City, Iowa. Medical Science Training Program, University of Iowa, College of Medicine, Iowa City, Iowa. Molecular and Cellular Biology Program, University of Iowa, College of Medicine, Iowa City, Iowa. Immunology Program, University of Iowa, College of Medicine, Iowa City, Iowa. Holden Comprehensive Cancer Center, University of Iowa, College of Medicine, Iowa City, Iowa. weizhou-zhang@uiowa.edu.
University of Iowa · USNanjing Agricultural University · CN

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
INTERDISCIPLINARY IMMUNOLOGY TRAINING PROGRAMT32AI007260 · NIAID · UNIVERSITY OF IOWA · PI BUTLER, NOAH SULLIVAN, WU, LI · 1986 to 2023
$5.7M
University of Iowa Surgical Oncology Training GrantT32CA148062 · NCI · UNIVERSITY OF IOWA · PI WEIGEL, RONALD J · 2010 to 2020
$3.8M
Myofibroblasts, T cells and malignant cells interplay in breast cancer metastasisR00CA158055 · NCI · UNIVERSITY OF IOWA · PI ZHANG, WEIZHOU · 2012 to 2014
$714k
Flow Cytometry Cell SorterS10RR027219 · NCRR · UNIVERSITY OF IOWA · PI BALLAS, ZUHAIR K. · 2009 to 2009
$500k
Myofibroblasts, T cells and malignant cells interplay in breast cancer metastasisK99CA158055 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHANG, WEIZHOU · 2011 to 2011
$110k
NCI NIH HHS K99 CA158055NCI NIH HHS K99/R00 CA158055NCI NIH HHS P30 CA086862NCI NIH HHS P30CA086862NCI NIH HHS R00 CA158055NCI NIH HHS T32 CA148062NCRR NIH HHS 1S10 RR027219NCRR NIH HHS S10 RR027219NIAID NIH HHS T32 AI007260NIGMS NIH HHS T32 GM007337
6 · The paper itself

Abstract

It is not well understood how paracrine communication between basal and luminal cell populations in the mammary gland affects tumorigenesis. During ErbB2-induced mammary tumorigenesis, enriched mammary stem cells that represent a subpopulation of basal cells exhibit enhanced tumorigenic capacity compared with the corresponding luminal progenitors. Transcript profiling of tumors derived from basal and luminal tumor-initiating cells (TIC) revealed preferential loss of the noncanonical Wnt ligand WNT5A in basal TIC-derived tumors. Heterozygous loss of WNT5A was correlated with shorter survival of breast cancer patients. In a mouse model of ErbB2-induced breast cancer, Wnt5a heterozygosity promoted tumor multiplicity and pulmonary metastasis. As a TGFβ substrate, luminal cell-produced WNT5A induced a feed-forward loop to activate SMAD2 in a RYK and TGFβR1-dependent manner to limit the expansion of basal TIC in a paracrine fashion, a potential explanation for the suppressive effect of WNT5A in mammary tumorigenesis. Our results identify the WNT5A/RYK module as a spatial regulator of the TGFβ-SMAD signaling pathway in the context of mammary gland development and carcinogenesis, offering a new perspective on tumor suppression provided by basal-luminal cross-talk in normal mammary tissue.

Indexed as

Cell ProliferationAnimalsBreast NeoplasmsFemaleKaplan-Meier EstimateLung NeoplasmsMice, Inbred C57BLNeoplastic Stem CellsParacrine CommunicationProto-Oncogene ProteinsSmad2 ProteinTranscriptomeTransforming Growth Factor betaWnt-5a ProteinWnt ProteinsProto-Oncogene ProteinsSmad2 ProteinSMAD2 protein, humanTransforming Growth Factor betaWnt-5a ProteinWNT5A protein, humanWnt Proteins

Identifiers

PMID25769722
PMCPMC4433621
OpenAlexW2015724624

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.